Carcinoma Squamous Equipment
-
based in USA
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment factors, enabling more informed choices about treatment and follow-up ...
-
Manufactured by Creative BioMartbased in USA
Keratin 8 belongs to the type B (basic) subfamily of high molecular weight keratins and exists in combination with keratin 18. Keratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular ...
-
Manufactured by NeraCare GmbHbased in GERMANY
Melanoma is a serious form of skin cancer that begins in cells known as melanocytes. While it is less common than basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), melanoma is far more dangerous because of its ability to spread to other organs more rapidly if it not treated at an early ...
-
based in USA
By delivering a precise, calibrated dose of Superficial Radiation Therapy that only goes skin deep, patients can be safely treated right in their physician’s office. Each treatment is virtually painless. Low-dose Superficial Radiation Therapy effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the ...
-
Manufactured by Shanghai Henlius Biotech, Incbased in CHINA
in conjunction with in-house products of the company and innovative therapies, and has initiated many clinical trials on immuno-oncology combination therapies of HANSIZHUANG worldwide, covering a wide range of indications, such as lung cancer, esophageal carcinoma, head and neck squamous cell carcinoma and gastric cancer, ...
-
Manufactured by Episkinbased in FRANCE
The SkinEthicTM HOE model is composed of TR146 cells (derived from a squamous cell carcinoma of the buccal mucosa) cultivated on an inert polycarbonate filter at the air liquid interface in a chemically defined medium. This model forms an epithelial tissue devoid of stratum corneum, resembling histologically to the mucosa of the oral ...
-
Manufactured by GeneCentric Therapeutics, Inc.based in USA
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung cancer (NSCLC), squamous cell carcinoma, and ...
-
Manufactured by AVITA Medicalbased in USA
Epidermolysis Bullosa (EB) is a group of rare and incurable skin disorders caused by mutations in genes encoding structural proteins resulting in skin fragility and blistering, leading to chronic wounds and, in some sub-types, an increased risk of squamous cell carcinoma or death. Dystrophic EB is estimated to affect 3-8 million ...
-
Manufactured by GeneCentric Therapeutics, Inc.based in USA
Head and Neck Cancer, a group of cancers that starts within the mouth, nose, throat, larynx, sinuses, or salivary glands, is the seventh most common of all cancers. Because most majority begin in squamous cells which line the moist surfaces inside the head and neck areas, such cancers are also referred to as Head and Neck Squamous Cell ...
-
Manufactured by Medinfar Groupbased in PORTUGAL
Actinic Keratosis is a very common skin disease characterized by superficial lesions, which appear on skin that has been exposed to the sun. (1);(2). Actinic Keratosis are deemed pre-cancerous lesions because they can evolve into squamous cell carcinoma. As such, ALL ACTINIC KERATOSIS MUST BE TREATED. Actinic Keratosis usually appear as ...
-
Manufactured by Fujirebiobased in USA
CanChek Tumor Marker Control Serum is intended for use as an assayed quality control serum to monitor the accuracy of laboratory testing for neuron specific enolase (NSE), S100B protein and squamous cell carcinoma antigen (SCCA). The use of a quality control serum is indicated to verify the performance characteristics of an in vitro ...
-
Manufactured by Rubius Therapeutics, Inc.based in USA
Study Title: Open-label, multicenter, multidose, first-in-human, Phase 1/2 study of RTX-224 for the treatment of patients with relapsed or refractory, or locally advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast ...
-
Manufactured by TC BioPharmbased in UNITED KINGDOM
cancer per year in the US. It is also implicated in cancers associated with infection by Epstein-Barr Virus (EBV). Previous efforts to target B7-H4 expression have been limited by off-tumor toxicity which makes it an ideal candidate for GDTs with a Co-stim CAR. Additionally, B7-H4 is a potential cancer stem cell marker in esophageal squamous ...
-
Manufactured by EDM3 Solutionsbased in USA
Tissue staining is the cornerstone of Mohs Micrographic Surgery (MMS). EDM3s new “all inclusive” Mohs Lab Staining Kit, will consistently yield slides with the highest quality, excellent morphology and differentiation of target cellular components. The kit includes marking dyes, freezing medium, bleaching reagents, both Hematoxylin and Eosin (H&E) and Toluidine Blue (T-blue) ...
-
Manufactured by Holostem Terapie Avanzate S.r.l.based in ITALY
Epidermolysis Bullosa (EB) is a group of genetic adhesion disorders characterized by fragility of the skin. EB are devastating, highly disfiguring, blistering pathologies that severely impairs the quality of life of patients and affect approximately 500,000 people worldwide ...
-
Manufactured by Radiopharm Theranosticsbased in AUSTRALIA
Nano-mAbs is the invention of Dr Hong Hoi Ting, an internationally regarded radiopharmaceutical and nuclear medicine expert, formerly from the University of ...
-
Manufactured by AVEO Pharmaceuticals, Inc.based in USA
Ficlatuzumab (formerly known as AV-299) is a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity. HGF is the natural ligand of c-Met and blocking HGF inhibits signaling through the HGF/c-Met signaling ...
-
Manufactured by MEDlight GmbHbased in GERMANY
Painfree Compact Daylight PDT; Enhanced conventional PDT; Large adjustable treament area; New touchscreen with many features; Highly flexible and adjustable device arm; Premium design with durable high quality ...
-
based in USA
Rigosertib is a small molecule that inhibits multiple cellular signaling pathways driving cancer cell growth while having little effect on normal cells. In contrast to many kinase inhibitors, rigosertib does not interact at the ATP binding site, but acts via allosteric inhibition. Rigosertib has the potential to affect three critical pathways for cancer cell proliferation and survival: the ...
-
Manufactured by GeneCentric Therapeutics, Inc.based in USA
Bladder cancer is one of the most common types of cancer which like lung and other cancers, is quite heterogeneous. Bladder cancer occurs more frequently in men than women, generally at an older age, and is more common among smokers than non-smokers. The most common type of bladder cancer begins within cells that line the inside of the bladder, urothelial cells – also called transitional ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you